Patent assignee · US · COMPANY

Lpath, Inc.

23Patents
23Active
23Granted
46Portfolio score

Filing activity: Oct 28, 2005 → Sep 27, 2011 · 20 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7829674B2 Compositions and methods for binding sphingosine-1-phosphate Chemistry; Metallurgy 12 Active
US7901682B2 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation Physics 6 Active
US8604172B2 Humanized antibody compositions and methods for binding lysophosphatidic acid Chemistry; Metallurgy 4 Active
US8158124B2 Compositions and methods for binding lysophosphatidic acid Physics 4 Active
US8614103B2 Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions Chemistry; Metallurgy 4 Active
US8067549B2 Humanized antibodies and compositions for binding sphingosine-1-phosphate Chemistry; Metallurgy 2 Active
US8025877B2 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate Chemistry; Metallurgy 2 Active
US8871202B2 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate Chemistry; Metallurgy 1 Active
US8796429B2 Bioactive lipid derivatives, and methods of making and using same Chemistry; Metallurgy 1 Active
US8026342B2 Compositions and methods for binding sphingosine-1-phosphate Chemistry; Metallurgy 1 Active
US7862812B2 Methods for decreasing immune response and treating immune conditions Chemistry; Metallurgy 1 Active
US8444970B2 Compositions and methods for treating ocular diseases and conditions Chemistry; Metallurgy 1 Active
US9274129B2 Methods and reagents for detecting bioactive lipids Chemistry; Metallurgy 0 Active
US9274130B2 Prevention and treatment of pain using antibodies to lysophosphatidic acid Chemistry; Metallurgy 0 Active
US9217749B2 Immune-derived moieties reactive against lysophosphatidic acid Chemistry; Metallurgy 0 Active
US9163091B2 Compositions and methods for binding lysophosphatidic acid Chemistry; Metallurgy 0 Active
US8361465B2 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents Chemistry; Metallurgy 0 Active
US7956173B2 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate Chemistry; Metallurgy 0 Active
US7794713B2 Compositions and methods for the treatment and prevention of hyperproliferative diseases Chemistry; Metallurgy 0 Active
US8401799B2 Antibody design using anti-lipid antibody crystal structures Physics 0 Active
US8222373B2 Humanized antibodies and compositions for binding sphingosine-1-phosphate Chemistry; Metallurgy 0 Active
US9181331B2 Pharmaceutical compositions for binding sphingosine-1-phosphate Chemistry; Metallurgy 0 Active
US9102718B2 Anti-S1P antibody treatment of patients with ocular disease Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.